Zymergen researches, develops and manufactures microbes. It develops molecules for biomedical coatings and adhesives that can be used as surgical glues by first responders, such as firemen, paramedics, flight crews and others either inside the body or on the skin to close a wound or to protect against infection. The Company uses a technology platform to optimize strains in that improves economics, improves the existing production strains within existing manufacturing processes and improves the correlation between the lab and commercial manufacturing.
Emeryville, US
Size (employees)
405 (est)+3%
Zymergen was founded in 2013 and is headquartered in Emeryville, US
Report incorrect company information

Key People/Management at Zymergen

Judy Gilbert

Judy Gilbert

Chief People Officer

Zymergen Office Locations

Zymergen has offices in Seattle and Emeryville
Emeryville, US (HQ)
5980 Horton St, Suite105
Seattle, US
2200 Alaskan Way
Show all (2)
Report incorrect company information

Zymergen Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$174.1 m

Latest funding size

$130 m

Time since last funding

2 years ago


Zymergen's latest funding round in October 2016 was reported to be $130 m. In total, Zymergen has raised $174.1 m
Report incorrect company information